Mounjaro is more effective for weight loss than Ozempic—how does it work? And why does it cost so much?
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness,
Weight loss injections: How do drugs like Wegovy and Mounjaro work?
Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, thigh or stomach. They work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).
Weight loss drugs could help with alcohol, opioid addiction, study says
Drugs​ like Mounjaro and Ozempic, which many use for weight loss,​​ may also help patients suffering from addiction, according to a new study.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs like Ozempic and Mounjaro, which also treat diabetes, may help users battling drug and alcohol abuse as well. A study published in the Addiction medical journal Wednesday showed roughy 1.
Ozempic: Weight Loss Drug May Help With Addiction Too
These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.
The Case for Ozempic as a Addiction Treatment Keeps Getting Better
Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's addiction to both opioids and alcohol.
Ozempic could help with opioid and alcohol abuse, new research shows
A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder. This is the second study this fall to suggest that GLP-1s,
Ozempic Could Be Used to Treat Alcohol and Drug Addiction, Study Finds
In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.
Eli Lilly (LLY): Revenue Boost from Zepbound and Mounjaro Amid Strong Market Projections
We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...
USA Today3d
There's a big Ozempic controversy brewing online. Doctors say it's the 'wild west.'
Martin received a prescription for a compounded drug containing tirzepatide − the active ingredient also found in Mounjaro and Zepbound. Martin has lost about 80 pounds since and continues to ...
ConsumerAffairs2d
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
Trade group sues FDA over ending Mounjaro/Zepbound shortage
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Becker's Hospital Review4d
FDA to reconsider decision barring sale of compounded Mounjaro: 5 things to know
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
BioPharma Dive4d
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
The Hill5d
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years. Pharmacies that sold unbranded ...
Wes Streeting’s jabs are no panacea – my own experience of Mounjaro was miserable
It was the insistent questioning of my four-year-old grandson that goaded me into it. “Why is your tummy so big” he asked ...